CME Group (CME) concentration risks

The company's disclosed concentration profile is narrow, consisting of a single customer-revenue claim. One firm represented 12% of clearing and transaction fees revenue for 2025 — a low individual share by disclosed size, with a dependency character. For an exchange operator processing transactions across a broad universe of market participants, a 12% share from a single firm indicates that revenue is generally well-distributed across the customer base, but this one relationship is large enough to be worth monitoring. The low-share designation means the exposure is not at a level that would independently move the investment verdict in either direction: a loss of this single client's activity would be material at the margin but would not represent a structural threat to the business. The dependency character is relevant in the sense that the relationship reflects a specific trading firm's activity levels and product mix preferences rather than a structural feature of the exchange's market position. No geographic, product, supplier, or regulatory concentration is separately disclosed. On balance, this is a modest and well-disclosed concentration profile consistent with the diversified, multi-asset-class nature of the exchange business, and the single named firm exposure is informative for monitoring purposes rather than a dominant risk factor in the investment thesis.

For the engine’s reasoning on CME’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.